Management of Chronic Nonbacterial Prostatitis/Chronic Pelvic Pain Syndrome

Chronic nonbacterial prostatitis/chronic pelvic pain syndrome is unsatisfactorily defined and insufficiently studied illness. Also, the treatment success is questionable and therefore, this illness is a therapeutical problem for urologists - which medications are the best choice in treating this unc...

Full description

Bibliographic Details
Main Authors: Benjamin Kulovac, Damir Aganović, Alden Prcić, Osman Hadžiosmanović
Format: Article
Language:English
Published: Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2007-08-01
Series:Biomolecules & Biomedicine
Subjects:
Online Access:https://www.bjbms.org/ojs/index.php/bjbms/article/view/3053
_version_ 1797260826646675456
author Benjamin Kulovac
Damir Aganović
Alden Prcić
Osman Hadžiosmanović
author_facet Benjamin Kulovac
Damir Aganović
Alden Prcić
Osman Hadžiosmanović
author_sort Benjamin Kulovac
collection DOAJ
description Chronic nonbacterial prostatitis/chronic pelvic pain syndrome is unsatisfactorily defined and insufficiently studied illness. Also, the treatment success is questionable and therefore, this illness is a therapeutical problem for urologists - which medications are the best choice in treating this uncomfortable condition? This paper presents results of prospective, open, analytical, comparative study that was performed on 90 patients with diagnosed chronic nonbacterial prostatitis/chronic pelvic pain syndrome. Patients were divided into three groups and were treated with two medications ciprofloxacin (C), doxazosin (D) and combination of ciprofloxacin + doxazosin (C+D). The effects were measured using symptom questionnaire for prostate illnesses of the National Institute for Health - USA (NIH-CPSI). During the basic evaluation, sum ranging from 0 to 43 was calculated for each patient. This number is called total sum NIH-CPSI (National Institutes of Health Chronic Prostatitis Symptom Index) of the questionnaire, which generates the questions from 1 to 9. The most significant change occurred in C+D group where the total sum changed from 18-38 in the beginning to 5-31 at the end of the treatment (55,1% (p<0,001)). Significant changes were also found in D group where the change was 46, 4% (p<0,001). At the end of the treatment no significant change was registered in C group (p<0,005): p<0,001 – significance threshold. Combination of ciprofloxacin + doxazosin proved to be the best choice for treatment.
first_indexed 2024-04-24T23:31:30Z
format Article
id doaj.art-6fe2a00a99ca4617a33c9ff13363e946
institution Directory Open Access Journal
issn 2831-0896
2831-090X
language English
last_indexed 2024-04-24T23:31:30Z
publishDate 2007-08-01
publisher Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina
record_format Article
series Biomolecules & Biomedicine
spelling doaj.art-6fe2a00a99ca4617a33c9ff13363e9462024-03-15T14:38:13ZengAssociation of Basic Medical Sciences of Federation of Bosnia and HerzegovinaBiomolecules & Biomedicine2831-08962831-090X2007-08-017310.17305/bjbms.2007.3053626Management of Chronic Nonbacterial Prostatitis/Chronic Pelvic Pain SyndromeBenjamin Kulovac0Damir Aganović1Alden Prcić2Osman Hadžiosmanović3Urology Clinic, University of Sarajevo Clinics CentreUrology Clinic, University of Sarajevo Clinics CentreUrology Clinic, University of Sarajevo Clinics CentreUrology Clinic, University of Sarajevo Clinics CentreChronic nonbacterial prostatitis/chronic pelvic pain syndrome is unsatisfactorily defined and insufficiently studied illness. Also, the treatment success is questionable and therefore, this illness is a therapeutical problem for urologists - which medications are the best choice in treating this uncomfortable condition? This paper presents results of prospective, open, analytical, comparative study that was performed on 90 patients with diagnosed chronic nonbacterial prostatitis/chronic pelvic pain syndrome. Patients were divided into three groups and were treated with two medications ciprofloxacin (C), doxazosin (D) and combination of ciprofloxacin + doxazosin (C+D). The effects were measured using symptom questionnaire for prostate illnesses of the National Institute for Health - USA (NIH-CPSI). During the basic evaluation, sum ranging from 0 to 43 was calculated for each patient. This number is called total sum NIH-CPSI (National Institutes of Health Chronic Prostatitis Symptom Index) of the questionnaire, which generates the questions from 1 to 9. The most significant change occurred in C+D group where the total sum changed from 18-38 in the beginning to 5-31 at the end of the treatment (55,1% (p<0,001)). Significant changes were also found in D group where the change was 46, 4% (p<0,001). At the end of the treatment no significant change was registered in C group (p<0,005): p<0,001 – significance threshold. Combination of ciprofloxacin + doxazosin proved to be the best choice for treatment. https://www.bjbms.org/ojs/index.php/bjbms/article/view/3053chronic nonbacterial prostatitis/chronic pelvic pain syndrometherapy
spellingShingle Benjamin Kulovac
Damir Aganović
Alden Prcić
Osman Hadžiosmanović
Management of Chronic Nonbacterial Prostatitis/Chronic Pelvic Pain Syndrome
Biomolecules & Biomedicine
chronic nonbacterial prostatitis/chronic pelvic pain syndrome
therapy
title Management of Chronic Nonbacterial Prostatitis/Chronic Pelvic Pain Syndrome
title_full Management of Chronic Nonbacterial Prostatitis/Chronic Pelvic Pain Syndrome
title_fullStr Management of Chronic Nonbacterial Prostatitis/Chronic Pelvic Pain Syndrome
title_full_unstemmed Management of Chronic Nonbacterial Prostatitis/Chronic Pelvic Pain Syndrome
title_short Management of Chronic Nonbacterial Prostatitis/Chronic Pelvic Pain Syndrome
title_sort management of chronic nonbacterial prostatitis chronic pelvic pain syndrome
topic chronic nonbacterial prostatitis/chronic pelvic pain syndrome
therapy
url https://www.bjbms.org/ojs/index.php/bjbms/article/view/3053
work_keys_str_mv AT benjaminkulovac managementofchronicnonbacterialprostatitischronicpelvicpainsyndrome
AT damiraganovic managementofchronicnonbacterialprostatitischronicpelvicpainsyndrome
AT aldenprcic managementofchronicnonbacterialprostatitischronicpelvicpainsyndrome
AT osmanhadziosmanovic managementofchronicnonbacterialprostatitischronicpelvicpainsyndrome